CDR Health Expands Homebound Monoclonal Antibody Treatments to Qualified Patients Statewide
FOR IMMEDIATE RELEASE
June 1, 2022
All Press Inquires to be Directed to:
Steve Vancore: (850) 528-4109, firstname.lastname@example.org
Tallahassee, FL – After an announcement last month regarding the provision of in-home monoclonal antibody treatment services to qualified patients in the Northwest Region of Florida, CDR Health—a leader in COVID-19 monoclonal antibody treatments, testing, and vaccinations in Florida—is expanding its services statewide. With the goal of meeting people where they are to make treatment options accessible to all, the in-home service is designed for individuals who are homebound and unable to seek treatment due to health or mobility reasons.
CDR Health is offering Bebtelovimab and Evusheld. Bebtelovimab is an FDA-authorized monoclonal antibody therapy used for the treatment of mild-to-moderate COVID-19 infection. Evusheld is a preventative monoclonal antibody treatment for immunocompromised patients who cannot mount a sufficient immune response to COVID-19 vaccination. Both treatments are administered in-home, in 2-hour appointments (including a 1-hour observation period to ensure the patient does not have any adverse reactions).
“Our team is extremely proud to expand this service to all Floridians across the state to help protect individuals in underserved communities where treatment options have been limited,” said CDR Health CEO, Tina Vidal-Duart. “We are uniquely prepared to offer in-home services so that accessibility never keeps a patient from receiving the care he or she needs.”
Treatments for qualified homebound Floridians will begin on Friday, June 3, and patients can begin booking appointments today, June 1. To register for a homebound monoclonal antibody treatment appointment, visit www.patientportalfl.com, email email@example.com, or call 833-930-3672. This service is free with insurance, Medicare, or Medicaid.
CDR Health is one of the leading COVID-19 testing, vaccination, and monoclonal antibody therapy providers on the forefront of the COVID-19 response. Their team has been advising multiple state and local governments since the beginning of the pandemic, providing valuable resources and supplies in response to COVID-19. CDR’s proprietary software, CDR HealthPro™, is designed to collect and keep track of patient data, integrating all patient, county, state, and federal needs into one streamlined portal. CDR Health has provided over 4 million COVID-19 tests, 2.7 million COVID-19 vaccinations, and 150,000 monoclonal antibody treatments.